Global B2B Pharmaceutical Sourcing ยท Dossier Licensing ยท Named-Patient Access
๐Ÿ’ฌ WhatsApp ยท Sign in ยท Register

Oncology Cancer Care โ€” Manufacturers, Suppliers & Exporters

Can't find the Oncology Cancer Care product you need?
Send us an RFP โ€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP โ†’

Browse Oncology Cancer Care products

Epirubicin Hydrochloride

Strength: 50 mg

Form: Injection

Reference Brands: Ellence (US), Farmorubicin (EU)

View Details Get Enquiry

Epirubicin Hydrochloride

Strength: 10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL

Form: Injection (IV)

Reference Brands: Ellenceยฎ (US) , Farmorubicinยฎ(EU)

View Details Get Enquiry

Erdafitinib

Strength: 3 mg, 4 mg, 5 mg

Form: Tablets

Reference Brands: Balversa (USA)

View Details Get Enquiry

Eribulin mesylate

Strength: 0.44 mg/mL

Form: Injection

Reference Brands: HALAVEN (USA/EU)

View Details Get Enquiry

Erlotinib

Strength: 25 mg, 100 mg, 150 mg

Form: Oral Tablets

Reference Brands: Tarceva (US & EU), Erlocip (India)

View Details Get Enquiry

Essential Trace Minerals with Lycopene Tablets

Strength: 30gm

Form: tablets

Reference Brands:

View Details Get Enquiry

Etoposide

Strength: 50 mg

Form: Capsules

Reference Brands: Vepesid, Toposar (US)

View Details Get Enquiry

Etoposide

Strength: 100 mg

Form: Injection

Reference Brands: Vepesid, Toposar (US)

View Details Get Enquiry

Etoposide

Strength: Injection: 20 mg/mL; Capsule: 50 mg

Form: Oral Capsules & Injection:

Reference Brands: US: Toposarยฎ (injection) VePesidยฎ (capsules); EU: Etopophosยฎ (injectable phosphate form) Vepesidยฎ (capsules)

View Details Get Enquiry

Exemestane

Strength: 25 mg

Form: Tablets

Reference Brands: Aromasin (USA/EU)

View Details Get Enquiry

Fedratinib

Strength: 100mg, 200mg

Form: Capsules

Reference Brands: Inrebic (USA/EU)

View Details Get Enquiry

Floxuridine

Strength: 500 mg

Form: Injection

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.